Discover why BTK inhibitors have attracted interest for treating multiple sclerosis, as a few late-stage candidates close in ...

A growing understanding of how “reproductive” hormones sculpt the brain could transform the management of neurological ...

Multiple sclerosis (MS) is a chronic autoimmune disorder affecting the central nervous system, often emerging in early adulthood and representing a leading cause of neurological disability in young ...

A new study has identified the protein hnRNP A1 as a key player in the production and maintenance of myelin, the fatty sheath ...

Research published in the Journal of Neurochemistry has detailed the role of a protein, hnRNP A1, in the formation and ...

Research published in the Journal of Neurochemistry has detailed the role of a protein, hnRNP A1, in the formation and ...

Tolebrutinib, a novel BTK inhibitor that targets neuroinflammation, slowed disability progression by 31% in nrSPMS, a phase 3 ...

Depression and anxiety have been well documented in people with multiple sclerosis (MS), but often are undiagnosed or ...

A Cleveland Clinic-led clinical trial of tolebrutinib, an investigational oral Bruton's tyrosine kinase inhibitor, a group of drugs originally developed to treat lymphomas and related blood disorders, ...

About multiple sclerosis Multiple sclerosis is a chronic, immune-mediated disease of the central nervous system that may result in accumulation ... that address the underlying causes of neurological ...

About multiple sclerosis Multiple sclerosis is a chronic, immune-mediated disease of the central nervous system that may result ... causes of neurological diseases and potentially transform ...

A new study published in Multiple Sclerosis and Related Disorders highlights the potential ... In MS, the body's own immune system attacks and damages the myelin. When myelin is lost, the axons ...